To know tha effect of churan and kwatha in tha management of Amavata w.s.r. to Rheumatoid Arthritis

A comparative clinical study to evaluate the effect of Pathyadi churan and Shunthyadi kwatha in the management of Amavata w.s.r. to Rheumatoid Arthritis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046617

Enrollment

Registered

2022-10-19

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing for study. Patients in the age group between 30-70 years, irrespective of sex and socio-economic status. Patient with signs and symptoms of Amavata w.s.r. to Rheumatoid Arthritis as described in texts and fulfill the diagnostic criteria.

Exclusion criteria

Exclusion criteria: Patients not willing for the trial Patients with age group below 30 and above 70 years. Allergy to the trial drug. Patients having any type of arthopathy such as neoplasm of spine,ankylosing spondylosis, osteoarthritis, traumatic arthritis and pyogenic osteomyelitis etc. Patients suffering from chronic renal, respiratory, cardiac and hepatic . disorder. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Relief in symptoms of Amavata after intervention of pathyadi churana and shunthayadi kwatha Angamarda Aruchi Trishna Alsaya Apaka Gaurava Jwara Sandhishoola Sandhishotha Sparshasahtva Vibandha Antrakujana Nidraviparyaya Praseka DahaTimepoint: 6 weeks	—

Secondary

Measure	Time frame
Improving quality of lifeTimepoint: 6 weeks	—

Countries

India

Contacts

Public ContactNavjot singh

Rajiv Gandhi Govt Post Graduate Ayurvedic college paprola

dr.skumarthakur@gmail.com9816195001

Outcome results